SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

VVOS

Vivos Therapeutics, Inc.
NASDAQHealth Care

Latest close: 0.13 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 8, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year249
SEC filings on record26610 flagged findings
Reported transactions (Form 4)28since Jun 14, 2023 · and 13 other holdings
Corporate events (8-K)30since Jun 13, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jun 8, 2026).

Deadline: Dec 2, 2026

  • stockholders' equity · Nasdaq, rule 5550(b)(1) · notice of Apr 17, 2026 · pending · no automatic period
  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Jun 5, 2026 · pending · deadline Dec 2, 2026 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:25 on Oct 27, 2023) · 1:25 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 266)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · Entered a material agreement new
  • Oct 1, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Sep 8, 268-K/A ↗Current report · Entered a material agreement · amendment
  • Sep 8, 268-K ↗Current report · Entered a material agreement
  • Sep 3, 26SCHEDULE 13G/A ↗Passive stake · Streeterville Capital LLC · 0.6% · amendment
  • Aug 26, 26Form 4 ↗Insider transaction
  • Aug 21, 268-K ↗Current report · Communication to the market
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 5.0% · event on Jun 30, 26 · amendment
  • Aug 11, 26SCHEDULE 13G ↗Passive stake · Streeterville Capital LLC · 9.3%
  • Aug 11, 268-K ↗Current report · Communication to the market
  • Aug 3, 268-K ↗Current report · Entered a material agreement
  • Jul 15, 26Form 4 ↗Insider transaction
  • Jul 15, 26Form 3 ↗Insider transaction
  • Jul 15, 26SCHEDULE 13D ↗Stake with intent to influence · SP Manager LLC · 19.9% · event on Jun 30, 26
  • Jul 7, 268-K ↗Current report · Entered a material agreement
  • Jun 25, 268-K ↗Current report · Entered a material agreement
  • Jun 16, 268-K ↗Current report · Other events
  • Jun 16, 268-K ↗Current report · Entered a material agreement
  • Jun 8, 268-K ↗Current report · Listing notice (8-K 3.01)
  • May 20, 2610-Q ↗Quarterly report
  • May 15, 26NT 10-Q ↗Late filing notice

266 filings on record, the oldest from Sep 25, 20.

Listing the 25 most recent filings of the 266 on record.

8-Ks, explained

Stress10Structure47Governance9
  • Oct 15, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Oct 1, 26GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Structure6 material agreements entered2026show all 6hide
    • Sep 8, 26StructureEntered a material agreement+2 more in the same filing8-K/A 1.01 ↗
    • Sep 8, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Aug 3, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jul 7, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jun 25, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jun 16, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 8, 26StressListing notice (8-K 3.01)+5 more in the same filing8-K 3.01 ↗
  • Apr 22, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 3, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Feb 6, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 20, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Jan 16, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Dec 5, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 25, 25StructureCompleted an acquisition or disposal+2 more in the same filing8-K/A 2.01 ↗
  • Jun 13, 25StructureTook on a new financial obligation+4 more in the same filing8-K 2.03 ↗

The record reaches back to Dec 15, 20.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 17, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 21, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 21, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 26, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Mar 27, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 29, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Nov 22, 22StressPast accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗
  • Nov 4, 22StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 10 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • SP Manager LLC19.9%Jun 30, 26SCHEDULE 13D ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • V-CO Investors LLC9.9%Dec 17, 24SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dawei Luo8.5%Jul 8, 25SCHEDULE 13G ↗
  • Armistice Capital, LLC5.0%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Mitchell P. Kopin5.0%Dec 22, 24SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Streeterville Capital LLC0.6%Sep 3, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Mar 31, 26Buy$1.4MMichael C Skaff↗
  • Mar 31, 26Buy$414KMichael C Skaff↗
  • Jun 20, 23Buy$7KRonald Kirk HuntsmanChief Executive Officer↗
  • Jun 16, 23Buy$5KRonald Kirk HuntsmanChief Executive Officer↗
  • Jun 16, 23Buy$3KRonald Kirk HuntsmanChief Executive Officer↗
  • Jun 15, 23Buy$11Ronald Kirk HuntsmanChief Executive Officer↗
  • Jun 14, 23Buy$5KRonald Kirk HuntsmanChief Executive Officer↗
Stock compensation, tax and giftsshow the 2 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jul 31, 26Compensation$103KBradford K. AmmanPrincipal Accounting Officer↗
  • Jun 30, 26Other$50KRonald Kirk HuntsmanChief Executive Officer↗

The full record holds 9 transactions and goes back to Jun 14, 23.

Its sector and its market

Vivos Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Vivos Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Vivos Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
249 clean closes in the period.
SEC records
266 documents on file, from Sep 25, 2020 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.